Glaukos Corp
Manufacturing · California, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
1 Glaukos Way, Aliso Viejo, California, ...Phone Number
(949) 367-9600Website
www.glaukos.comRevenue
$551.3 MillionStock Symbol
GKOSIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
5
5
1
1
1
1
About Glaukos Corp
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.Explore more
Glaukos Corp Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Glaukos Corp your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Glaukos Corp had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Glaukos Corp has new funding data
Product Launch: Get notified when Glaukos Corp launches new products
Check if Glaukos Corp has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Glaukos Corp
Earning: See what the market has to say on Glaukos Corp recently announced quarterly report
Glaukos Corp, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Glaukos Corp is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Glaukos Corp
Compare insights from companies similar to Glaukos Corp, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Glaukos Corp
$551.3M
1K - 5K
Public
$187.3M
1998
AT
Alexander ThurmanSenior Vice President & Chief Financial Officer
$408.5M
1K - 5K
Private
$921.8M
2006
SR
Shana RossSenior Vice President and Chief Human Resources Officer
Company Profile Activity
Activity Insights
Glaukos Corp is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Glaukos Corp is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Glaukos Corp.
Glaukos Corp financials insights
Gather financial insights about Glaukos Corp, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2002
Series A
$10M
2008
Series D
$35M
2013
Series F
$30M
2015
Stock Offering
$112.3M
Glaukos Corp Tech Stack
A closer look at the technologies used by Glaukos Corp
See more technologies
Most Recent Scoops
Hiring Plans
Glaukos Corp has more open roles in Engineering & Technical than it has had at any time in the past 6 months. Technologies mentioned include: Helix ALM, and Helix SIEM. Areas of expertise include: Technical Documentation, Technical Support, and Customer Relationship Building.
Hiring Plans
Hiring Plans
Glaukos Corp has more open roles in Sales than it has had at any time in the past 12 months. Technologies mentioned include: Showpad, SugarCRM, Salesforce Sales Cloud, and Salesforce. Areas of expertise include: Territory Expansion, and Medical Sales.
Hiring Plans
Open Position
Open Position
Open Position
Glaukos Corp News & Media
Strong Results with 38.1% Revenue Growth Lifted Glaukos (GKOS) in Q4
Brown Capital Management, an investment management company, released its fourth quarter 2025 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be downloaded here. In the fourth quarter of 2025, the Small Company Fund (Investor shares) fell 1.50%, behind the Russell 2000® Growth index’s 1.22% gain. Real estate and […]Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript
Glaukos Corporation (GKOS) Q4 2025 Earnings Call February 17, 2026 4:30 PM ESTCompany ParticipantsChristopher Lewis - Vice President of Investor Relations...Director Sells GKOS 15,000 Shares for $1.9 Million
This ophthalmic device maker, focused on glaucoma solutions, reported a notable insider sale after a challenging year for its stock.What Makes Glaukos (GKOS) a Good Investment?
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund focuses on investing in a portfolio of 50 small and mid-cap companies with promising growth potential. The US equity market ended the fourth quarter on a strong […]
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Glaukos Corp
Sign Up For FreeTo access detailed company insights
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate ope... Read More
